TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PRPO

Precipio Inc

Healthcare · Diagnostics & Research

23.40$ -0.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement PRPO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -93.9% -5.8% +10.7% +66.2% +9.2% +94.8% +45.3% +6.4% +61.5% +5.1% +50.6%
– -88.8% -9.2% -18.8% +84.4% +10.2% +69.9% +30.7% +6.9% +33.0% -8.4% +58.7%
– -103.0% – – -22.9% -2.7% +425.1% +108.0% +4.9% +139.8% +25.6% +41.6%
– -36.0% -23.3% -64.8% +120.0% +153.6% -21.1% +4.5% +17.4% +0.0% -14.8% –
– -70.8% -12.2% +4.8% +45.7% +0.8% +7.1% +16.8% +27.7% -11.0% -13.8% –
– -67.1% -14.5% -14.8% +45.7% +18.6% -8.2% +16.6% +27.5% -10.9% -13.7% +1.1%
– – – – – – – – – – – –
– +8.9% -28.5% +348.6% -31.3% -70.4% -0.6% -95.7% -40.0% +50.0% +311.1% -1.4%
– – – – – – – – – – – –
– +4,434.2% -100.9% – -102.0% – – -98.0% -24.2% +5,296.4% – –
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?